Miranda Grubb

Background

About Miranda Grubb

Kerecis is pioneering the use of fish skin and fatty-acids in the globally expanding cellular therapy and regenerative medicine market. The fatty-acid rich (including Omega3) products from the company's patented technologies enable the body to regenerate tissues, rather than simply repair them and risk scarring. The Kerecis products, which are based on Omega3 rich fish skin, are currently being used to regenerate tissue in trauma and chronic wounds such as burns and diabetic wounds. Kerecis is also developing products for areas such as oral surgery, plastic surgery and neurological applications. The company's mission is to extend human life by supporting the body's own ability to regenerate tissues and its vision is to become world leader in regenerating damage of the human body by sustainably harnessing nature's own remedies. The vision of Kerecis is to become world leader in regenerating damage of the human body by sustainably harnessing nature’s own remedies. The Kerecis mission is to extend human life by supporting the body’s own ability to regenerate